Optimising the depression pathway enabled by novel digital assessment technology

通过新型数字评估技术优化抑郁症途径

• 批准号: 104641
• 金额: $ 87.76万
• 依托单位: P1VITAL PRODUCTS LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2019
• 资助国家: 英国
• 起止时间: 2019 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=104641
• 关键词: Optimising; depression; pathway; enabled; novel

"Depression is the leading cause of disability in the UK today with over a million people seeking or receiving treatment at any one time. However, for patients, finding the right treatment can be difficult particularly at a vulnerable time in their lives. For many patients even effective treatment can take weeks and often months to work, and support during recovery can be hard to find. Many patients seek help from their GPs, but may have to wait some time for what can be perceived as a non-urgent appointment. Moreover, the assessment and treatment provided by GP practices varies widely across the country and the quality of care critically depends on the availability of GPs with specialist knowledge of mental health conditions. We aim to significantly improve the treatment of low mood and depression by implementing innovative digital technologies that empower healthcare professionals to better diagnose mental health problems and get patients on to the right treatment sooner than existing methods. The project will assess an optimised depression pathway to improve choice and access to quality care for people with low mood and depression. We will implement a systematic approach to the treatment of depression through local health centres providing a 'walk-in' service with access to a range of healthcare professionals with specialist training and supported by innovative digital technology. Our project brings together GPs, healthcare professionals and charities in one place with the aim of quickly identifying the most appropriate treatment for each patient. Early intervention and monitoring enabled by digital technology is designed to improve outcomes by ensuring that if symptoms escalate, patients can be efficiently and effectively switched to better treatments sooner. This digitally enabled precision medicine approach will reduce the need for referrals to scarce secondary and crisis care services and free up time for GPs to focus on the most severe cases.Initially, this innovative program will be implemented, evaluated and refined in selected GP practices in Kent. Critical to this work is the involvement of patients to ensure that existing concerns and problems faced by them when seeking help with depression are addressed. Such patient involvement is supported by MIND, a charity specialising in supporting people with mental health conditions. Through this optimised depression pathway, enabled by digital technologies we will wrap care around the patient returning them to good health sooner, thereby enabling them to return to the healthy, productive lives they desire."

“抑郁症是当今英国残疾的主要原因，有超过一百万人在任何时候寻求或接受治疗。然而，对于患者来说，找到正确的治疗可能很困难，尤其是在他们生命中的脆弱时期。对于许多患者来说，即使有效的治疗也可能需要数周甚至数月的时间才能发挥作用，并且在康复期间很难找到支持。许多患者向全科医生寻求帮助，但可能需要等待一段时间才能获得被视为非紧急的预约。此外，提供的评估和治疗 全国范围内全科医生的做法差异很大，护理质量主要取决于是否有具备心理健康状况专业知识的全科医生。我们的目标是通过实施创新的数字技术来显着改善情绪低落和抑郁症的治疗，使医疗保健专业人员能够比现有方法更好地诊断心理健康问题并让患者更快地接受正确的治疗。该项目将评估一条优化的抑郁症途径，以改善情绪低落和抑郁症患者的选择和获得优质护理的机会。我们 将通过当地医疗中心实施系统性的抑郁症治疗方法，提供“步入式”服务，让受过专业培训并得到创新数字技术支持的一系列医疗保健专业人员获得服务。我们的项目将全科医生、医疗保健专业人员和慈善机构聚集在一处，旨在快速确定每位患者最合适的治疗方法。由数字技术支持的早期干预和监测旨在通过确保如果症状升级，患者可以有效地得到治疗来改善结果 并更快地有效地转向更好的治疗方法。这种数字化精准医疗方法将减少转诊到稀缺的二级和危机护理服务的需求，并为全科医生腾出时间来专注于最严重的病例。最初，这一创新计划将在肯特郡选定的全科医生实践中实施、评估和完善。这项工作的关键是患者的参与，以确保他们在寻求抑郁症帮助时所面临的现有担忧和问题得到解决。这样的 患者的参与得到 MIND 的支持，MIND 是一家专门为患有心理健康问题的人提供支持的慈善机构。通过这种由数字技术支持的优化抑郁症途径，我们将围绕患者提供护理服务，让他们更快地恢复健康，从而使他们能够恢复他们想要的健康、富有成效的生活。”